We’re delighted to welcome Leone as Chair of the Board’s Audit Committee,” said David Hallal, Chairman of the Kalaris Board of Directors. “Leone is joining us at the pinnacle of her career as a senior ...

The first two episodes of Chief of War will premiere on Apple TV+ on Aug. 1, with new episodes every Friday through Sept. 19. The upcoming series also follows Apple TV+’s post-apocalyptic epic ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

KUALA LUMPUR: Keyfield International Bhd has appointed Goh Yet Loong as its new chief strategy officer, effective April 1, 2025. The workboat fleet operator said Goh will lead corporate strategy ...

In this article, we are going to take a look at where Tenaya Therapeutics, Inc. (NASDAQ:TNYA) stands against other cheapest stocks insiders are buying in March. After solid gains Monday ...

Wolfspeed has hired Robert Feurle as the electric-vehicle chip maker's new chief executive, effective May 1. Wolfspeed on Thursday said Feurle joins from Swiss chip maker ams-Osram, where he has ...

New RAAF chief Air Marshal Stephen Chappell has warned Australia is in a "strategic autumn" as potential threats grow across the Indo-Pacific. In his first interview, the air force chief has ...

Sharing the article on X (formerly Twitter), Patel underscored how the values of dharma, karma, and seva—righteous duty, action with accountability, and selfless service—have guided his ...

Credit: Senate Commerce Committee webcast WASHINGTON — The person nominated but not confirmed to be NASA’s chief financial officer (CFO) in the first Trump administration is getting another ...

0:41 Poilievre says he won Conservative leadership race ‘fair and square’ National security leaks are rare in Canada. They’re even more rare during fraught election campaigns. So the ...

Tenaya Therapeutics (TNYA) announced the publications of positive preclinical data for TN-201, the company’s gene therapy candidate for Myosin-Binding Protein C3-associated hypertrophic ...

M.D., Ph.D., Tenaya’s Chief Medical Officer. “The robust transduction and improvements in cardiac function observed in a model of severe disease, provide reason to believe in TN-201’s ...